These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37054940)

  • 1. Canagliflozin protects diabetic cardiomyopathy by mitigating fibrosis and preserving the myocardial integrity with improved mitochondrial function.
    Dasari D; Goyal SG; Penmetsa A; Sriram D; Dhar A
    Eur J Pharmacol; 2023 Jun; 949():175720. PubMed ID: 37054940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canagliflozin Mitigates Diabetic Cardiomyopathy through Enhanced PINK1-Parkin Mitophagy.
    Yang C; Xiao C; Ding Z; Zhai X; Liu J; Yu M
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
    Du S; Shi H; Xiong L; Wang P; Shi Y
    Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats.
    Diao J; Wei J; Yan R; Fan G; Lin L; Chen M
    J Physiol Biochem; 2019 Feb; 75(1):39-51. PubMed ID: 30225723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
    Bulani Y; Sharma SS
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
    Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
    Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes.
    Mangali S; Bhat A; Jadhav K; Kalra J; Sriram D; Vamsi Krishna Venuganti V; Dhar A
    Biochem Pharmacol; 2020 Jul; 177():113948. PubMed ID: 32251680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight fucoidan alleviates cardiac dysfunction in diabetic Goto-Kakizaki rats by reducing oxidative stress and cardiomyocyte apoptosis.
    Yu X; Zhang Q; Cui W; Zeng Z; Yang W; Zhang C; Zhao H; Gao W; Wang X; Luo D
    J Diabetes Res; 2014; 2014():420929. PubMed ID: 25525607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
    Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy.
    Ma T; Huang X; Zheng H; Huang G; Li W; Liu X; Liang J; Cao Y; Hu Y; Huang Y
    Oxid Med Cell Longev; 2021; 2021():9265016. PubMed ID: 34790288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
    Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
    Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats.
    Trang NN; Chung CC; Lee TW; Cheng WL; Kao YH; Huang SY; Lee TI; Chen YJ
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.
    Oguma T; Kuriyama C; Nakayama K; Matsushita Y; Yoshida K; Kiuchi S; Ikenaga Y; Nakamaru Y; Hikida K; Saito A; Arakawa K; Oka K; Ueta K; Shiotani M
    J Pharmacol Sci; 2015 Apr; 127(4):456-61. PubMed ID: 25892328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.
    Li XB; Rekep M; Tian JH; Wu Q; Chen M; Yang S; Zhang LX; Zhang GP; Qin Y; Yu XY; Xue Q; Liu YH
    Pharmacology; 2023; 108(1):47-60. PubMed ID: 36423586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.